Search results
A count of women and men diagnosed with metastatic breast cancer, and distant recurrence in 2024 (incidence) as well as prevalence which includes a count of women and men living with metastatic breast cancer.
This tool is produced by the National Disease Registration Service, and contains information on whether patients who are eligible for genetic testing after a cancer diagnosis are reported as tested for germline BRCA mutations. The data is broken down by factors such as geographical region (Cancer Alliance...
Latest publication: BRCA testing after a diagnosis of cancer, 2016-2020 diagnoses
Use of NICE-appraised medicines in the NHS in England
The Quality of Nationally Submitted Health and Social Care Data